Literature DB >> 3726070

The prevalence of tardive dyskinesia in a mentally retarded population.

M A Richardson, G Haugland, R Pass, T J Craig.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3726070

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  6 in total

1.  Tardive dyskinesia: update for the mental health administrator.

Authors:  J E Kalachnik; K M Slaw
Journal:  J Ment Health Adm       Date:  1986

2.  Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.

Authors:  H A Youssef; J L Waddington
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

3.  Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.

Authors:  Pattipati S Naidu; Amanpreet Singh; Shrinivas K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

4.  Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.

Authors:  Pattipati S Naidu; Amanpreet Singh; Shrinivas K Kulkarni
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?

Authors:  M L Rao; B Strebel; G Gross; G Huber
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

Review 6.  Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.

Authors:  R Antochi; C Stavrakaki; P C Emery
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.